| 阿莫西林克拉维酸钾复方制剂在社区获得性肺炎治疗中的作用 |
| |
| 引用本文： | 唐晓燕. 阿莫西林克拉维酸钾复方制剂在社区获得性肺炎治疗中的作用[J]. 中国全科医学, 2012, 15(20): 2330-2331 |
| |
| 作者姓名： | 唐晓燕 |
| |
| 作者单位： | 四川大学华西医院呼吸科,四川省成都市,610041 |
| |
| 摘 要： | 社区获得性肺炎(CAP)是临床常见的感染性疾病,在长期临床用药过程中,CAP的耐药性问题日益突出,阿莫西林克拉维酸钾复方制剂在CAP中的治疗地位由于其疗效显著而逐渐被肯定。阿莫西林克拉维酸钾复方制剂不同配比的给药方案抗菌疗效也不尽相同,本研究通过临床实验也给出了两者最佳配比。
|
| 关 键 词： | 社区获得性感染 肺炎 阿莫西林棒酸钾合剂 药代动力学 |
Role of Amoxicillin and Clavulanate Potassium in Treatment of Community-acquired Pneumonia |
| |
| TANG Xiao-yan. Role of Amoxicillin and Clavulanate Potassium in Treatment of Community-acquired Pneumonia[J]. Chinese General Practice, 2012, 15(20): 2330-2331 |
| |
| Authors: | TANG Xiao-yan |
| |
| Affiliation: | TANG Xiao-yan.Department of Respiratory Disease,West China Hospital of Sichuan University,Chengdu 610041,China |
| |
| Abstract: | Community-acquired pneumonia(CAP)is a common infectious disease.Its resistance has become increasingly prominent in long-term clinical course of medication.Amoxicillin and clavulanate potassium has been recognized gradually due to its significant effect on CAP.Different matching dosage regimen has different antimicrobial efficacy.This paper gives 2 best matching dosage regimens by clinical trials. |
| |
| Keywords: | Community-acquired infection Pneumonia Amoxicillin-potassium clavulanate combination Pharmacokinetics |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
